No abstract available
MeSH terms
-
Adult
-
Benzoates / administration & dosage*
-
Benzoates / adverse effects
-
Bleeding Time
-
Blood Loss, Surgical / prevention & control*
-
Coagulants / administration & dosage*
-
Coagulants / adverse effects
-
Drug Administration Schedule
-
Female
-
Genetic Predisposition to Disease
-
Heredity
-
Humans
-
Hydrazines / administration & dosage*
-
Hydrazines / adverse effects
-
Molecular Motor Proteins / genetics*
-
Mutation, Missense*
-
Myosin Heavy Chains / genetics*
-
Orthopedic Procedures / adverse effects*
-
Phenotype
-
Postoperative Hemorrhage / etiology
-
Postoperative Hemorrhage / prevention & control*
-
Pyrazoles / administration & dosage*
-
Pyrazoles / adverse effects
-
Severity of Illness Index
-
Thrombocytopenia / blood
-
Thrombocytopenia / complications
-
Thrombocytopenia / genetics*
-
Time Factors
-
Treatment Outcome
Substances
-
Benzoates
-
Coagulants
-
Hydrazines
-
MYH9 protein, human
-
Molecular Motor Proteins
-
Pyrazoles
-
Myosin Heavy Chains
-
eltrombopag